BRAINAURORA-B (06681) announced its interim results for the six months ended June 30, 2025. The group achieved revenue of RMB 100 million, representing a year-over-year increase of 92.82%. The adjusted net loss reached RMB 88.022 million, up 11.64% compared to the same period last year. Loss attributable to owners of the company totaled RMB 126 million, an increase of 10.53% year-over-year, with loss per share of RMB 0.11.

According to the announcement, the revenue increase was primarily driven by the growth in the number of hospitals purchasing the system, which increased from 186 in 2024 to 205 during the six months ended June 30, 2025. Additionally, patient usage of the company's system rose from approximately 1.8 million sessions in 2024 to 2.5956 million sessions in the six months ended June 30, 2025. The number of patients who initially used the system in hospitals and subsequently chose to use the system at home during the same period increased significantly from approximately 7,397 to 12,900 during the six months ended June 30, 2025.